We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$268B
AUM Growth
+$39.7B
Cap. Flow
+$21.8B
Cap. Flow %
8.14%
Top 10 Hldgs %
12.83%
Holding
12,049
New
1,180
Increased
5,214
Reduced
3,562
Closed
1,371

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$850M
2
AAPL icon
Apple
AAPL
+$778M
3
TSLA icon
Tesla
TSLA
+$569M
4
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$351M
5
JNJ icon
Johnson & Johnson
JNJ
+$336M

Sector Composition

Rank Sector Weight
1 Technology 10.83%
2 Healthcare 7.49%
3 Financials 7.15%
4 Consumer Discretionary 4.92%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRN icon
8826
Barnwell Industries
BRN
$14.5M
$7.36K ﹤0.01%
+2,485
New +$7.54K
EVLO
8827
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$7.35K ﹤0.01%
228
+97
+74% +$3.84K
VRPX
8828
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$7.35K ﹤0.01%
47
+22
+88% +$5.01K
LUMO
8829
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$7.34K ﹤0.01%
2,033
+1,291
+174% +$8.44K
LOKM
8830
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
$7.32K ﹤0.01%
728
AEHAU
8831
DELISTED
Aesther Healthcare Acquisition Corp Units
AEHAU
$7.32K ﹤0.01%
698
DSS icon
8832
DSS Inc
DSS
$5.02M
$7.31K ﹤0.01%
2,461
-1,595
-39% -$6.55K
SAIH
8833
SAIHEAT Ltd
SAIH
$38.9M
$7.3K ﹤0.01%
242
-41
-14% -$1.84K
RAIN
8834
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$7.3K ﹤0.01%
913
-785
-46% -$4.93K
FNVTU
8835
DELISTED
Finnovate Acquisition Corp. Units
FNVTU
$7.3K ﹤0.01%
711
CCEL icon
8836
Cryo-Cell International
CCEL
$28.8M
$7.29K ﹤0.01%
1,724
+1,587
+1,158% +$7.6K
FAZ
8837
Direxion Daily Financial Bear 3x ETF
FAZ
$85.7M
$7.29K ﹤0.01%
38
-448
-92% -$93.5K
SNRHU
8838
DELISTED
Senior Connect Acquisition Corp. I Unit
SNRHU
$7.27K ﹤0.01%
782
-18,883
-96% -$188K
PPHP
8839
DELISTED
PHP Ventures Acquisition Corp. Class A Common Stock
PPHP
$7.26K ﹤0.01%
700
+227
+48% +$2.33K
PERF icon
8840
Perfect Corp
PERF
$196M
$7.25K ﹤0.01%
+1,016
New +$7.51K
MDAI icon
8841
Spectral AI
MDAI
$52.8M
$7.22K ﹤0.01%
715
-43
-6% -$429
LEXI icon
8842
Alexis Practical Tactical ETF
LEXI
$189M
$7.21K ﹤0.01%
+314
New +$7.23K
DLCAU
8843
DELISTED
Deep Lake Capital Acquisition Corp. Unit
DLCAU
$7.21K ﹤0.01%
716
-849
-54% -$8.51K
GMVD
8844
DELISTED
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
$7.19K ﹤0.01%
+2,193
New +$10.3K
RCFA
8845
DELISTED
Perception Capital Corp. IV
RCFA
$7.18K ﹤0.01%
700
ADRT.U
8846
DELISTED
Ault Disruptive Technologies Corporation Units, each consisting of one share of Common Stock, and three-fourths of one Redeemable Warrant to purchase one share of Common Stock
ADRT.U
$7.18K ﹤0.01%
700
OLITU
8847
DELISTED
OmniLit Acquisition Corp. Units
OLITU
$7.18K ﹤0.01%
721
+90
+14% +$916
DYNT
8848
DELISTED
Dynatronics Corp
DYNT
$7.18K ﹤0.01%
+3,680
New +$8.29K
PME
8849
DELISTED
Pingtan Marine Enterprise Ltd.
PME
$7.17K ﹤0.01%
17,922
-23,925
-57% -$16.4K
HTAB icon
8850
Hartford Schroders Tax-Aware Bond ETF
HTAB
$289M
$7.17K ﹤0.01%
376
-420
-53% -$7.87K

Similar funds

UBS Group's Q4 2022 Portfolio in Review

As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,214 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.

  • UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
  • UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
  • UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
  • UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
  • UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
  • UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
  • UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.